Atlas Trials

Recurrent Sezary Syndrome

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Sezary Syndrome

RecordFirmDate
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab (NCT07003100)City of Hope Medical Center2024-12-06
Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment (NCT04541017)National Cancer Institute (NCI)2021-04-06

Track Recurrent Sezary Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.